Where is Biosite located?

Biosite is headquartered in Bengaluru, India.

How many employees does Biosite have?

As of Jul 01, 2024, the latest employee count at Biosite is 23.

Is Biosite a funded company?

Biosite is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Biosite rank among its competitors?

Biosite ranks 203rd amongst 795 active competitors, of which 52 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Superluminal Medicines, which secured $5M in Aug, 2025.

Who are the top competitors of Biosite?

Biosite's top competitors include Simulations Plus, Alloy Therapeutics and Manifold Bio. Among them, Superluminal Medicines secured the most recent funding round in August, 2025.

Biosite - 2026 Company Profile & Competitors

Biosite is an unfunded company based in Bengaluru (India), founded in 2015. It operates as a Provider of full and functional clinical research solutions. Biosite has not raised any funding yet. The company has 795 active competitors, including 52 funded and 47 that have exited. Its top competitors include companies like Simulations Plus, Alloy Therapeutics and Manifold Bio.

Company Details

Provider of full and functional clinical research solutions to biotech, pharmaceutical, and medical device industries. It offers customized end-to-end solutions to fulfill R&D and production needs, based on a security framework, quality record, compliance, and a strong supply chain. It guides clients from clinical development planning to regulatory filing, providing flexible solutions whilst ensuring budget and deadlines are met. It has therapeutic expertise to support trial execution, consulting, and placement solutions.

Key Metrics

Founded Year

2015

Location

Bengaluru, India

Stage

Unfunded

Ranked

203^rd among 795 active competitors

Employee Count

23 as on Jul 01, 2024

Similar Companies

Simulations Plus & 816 more

View Biosite's full profile

Biosite has not raised any funding rounds yet.

Biosite's employee count trend

Biosite has 23 employees as of Jul 24. Here is Biosite's employee count trend over the years:

Uncover Biosite's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Biosite include Simulations Plus, Alloy Therapeutics and Manifold Bio. Here is the list of Top 10 competitors of Biosite, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Simulations Plus 1996, Lancaster (United States), Public	Developer of modeling and simulation software and consulting services provider	-	FDA, NIH & 1 others	65/100
2nd	Alloy Therapeutics 2017, Lexington (United States), Series D	Provider of drug discovery services	$117M	8VC, Mubadala & 8 others	62/100
3rd	Manifold Bio 2018, United States, Series A	Developer of tissue-targeted therapeutics using in vivo screening and AI design	$78.2M	Playground Global, Triatomic & 8 others	61/100
4th	Maiva Pharma 1996, Hosur (India), Late Stage	Manufacturer of sterile injectables	$125M	Nhpea V Spear, Nano-Vista & 25 others	61/100
5th	VelaVigo 2021, Shanghai (China), Seed	Biotechnology research company developing biological drugs	$160M	Shunwei Capital, Panacea Venture & 17 others	56/100
6th	Biocom California 1995, San Diego (United States), Acquired	CRO focused on drug discovery & development for multiple therapeutic areas	-	-	55/100
7th	CILcare 2014, Montpellier (France), Series A	Service to develop health products aiming to diagnose, prevent, delay the progression or treat hearing loss and tinnitus	$42.3M	Shionogi, UVM Health & 4 others	53/100
8th	Viva Biotech 2006, Shanghai (China), Public	Research services focused on drug discovery and development	-	Temasek, ShenZhen GTJA Investment Group & 3 others	51/100
9th	Superluminal Medicines 2022, Boston (United States), Series A	Generative biological and chemical company focused on drug discovery	$158M	RA Capital Management, Insight Partners & 5 others	50/100
10th	Syenex 2022, Chicago (United States), Series B	Developer of cell-specific delivery systems and programmable cell engineering payloads	$13.7M	AlleyCorp, KdT Ventures	50/100
203rd	Biosite 2015, Bengaluru (India), Unfunded	Provider of full and functional clinical research solutions	-	-	21/100